Haleon plc
NYSE:HLNDrug Manufacturers - Specialty & Generic
+$0.08 today
- Market cap
- $39.85B
- Beta
- 0.25
- P/E (TTM)
- 29.2
- EPS (TTM)
- $0.11
- Dividend yield
- 2.13%
Volume 19.46M
Average 8.79M
HLN Other Non-Cash Items
Other non-cash adjustments that reconcile net income to operating cash flow.
Haleon plcNYSE: HLN
Other Non-Cash Items · Q4 FY2025 · quarter ended Dec 2025
Other non-cash items turns positive
Q4 FY2025 other non-cash items was £58.6M, compared with -£818M a year earlier. Over 3 fiscal years it compounded at -46.0% a year.
Context
- Other non-cash items amounted to 0.5% of revenue in FY2025, down 2.9 pp from a year earlier.
- Other non-cash items increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
Sources:Cash FlowText generated from reported figures; not investment advice.
Other Non-Cash Items history
GBP · from the cash flow
- Latest · FY2025
- 52.82M GBP
- Year-over-year change
- -86.3%
| Period | Period end | Other Non-Cash Items | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 52.82M | -86.3% |
| FY2024 | 2024-12-31 | 385M | -23.9% |
| FY2023 | 2023-12-31 | 506.04M | +50.6% |
| FY2022 | 2022-12-31 | 336M | +182.8% |
| FY2021 | 2021-12-31 | (406M) | — |
Other Non-Cash Items vs competitors
How HLN compares with its peers on the latest reported figures
- Peers report in different currencies, so other non-cash items is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -86.3% is the lowest of 6, against a peer median of +496.2%.
- Other non-cash items amounts to 0.5% of revenue for HLN, versus a peer median of 5.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $2.11B USD | +1526.4% | +123.6% | 50.9% | |
| LTM Jun 2026 | £1.69B GBP | +310.1% | — | 5.1% | |
| LTM Sep 2026 | $1.16B USD | +2376.6% | +20.4% | 5.5% | |
| LTM Sep 2026 | $939M USD | +496.2% | +90.6% | 6.0% | |
| LTM Sep 2026 | $74.8M USD | +17.2% | -32.1% | 1.2% | |
| FY2025 | £52.82M GBP | -86.3% | -46.0% | 0.5% | |
| Peer median (excluding HLN) | — | +496.2% | +55.5% | 5.5% | |
Competitors are the stored peer set for HLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 1.39B | 1.12B | 1.3B | 1.44B | 1.63B |
| Depreciation & Amortization | 268M | 287M | 309M | 324M | 352.11M |
| Deferred Income Tax | 197M | 62M | 0 | 0 | 0 |
| Stock-Based Compensation | 59M | 78M | 88M | 102M | 0 |
| Change in Working Capital | (152M) | 181M | (107M) | 48M | 250.39M |
| Accounts Receivables | 14M | (85M) | 38M | (312M) | (63.58M) |
| Inventory | (17M) | (292M) | (131M) | 216M | 130.09M |
| Accounts Payables | 41M | 387M | 112M | 0 | 122.26M |
| Other Working Capital | (190M) | 171M | (126M) | 144M | 61.62M |
| Other Non-Cash Items | (406M) | 336M | 506.04M | 385M | 52.82M |
| Operating Cash Flow | 1.36B | 2.06B | 2.1B | 2.3B | 2.29B |
| Capital Expenditures | (298M) | (328M) | (336M) | (250M) | (314.94M) |
| Acquisitions (Net) | 112M | 9.21B | (71M) | 0 | (157.47M) |
| Purchases of Investments | (112M) | (9.21B) | 0 | 0 | (5.87M) |
| Sales of Investments | 100M | 700M | 0 | 0 | 0 |
| Other Investing Activities | 165M | (9.16B) | 171M | 778M | 0 |
| Investing Cash Flow | (33M) | (8.78B) | (134M) | 528M | (567.29M) |
| Debt Repayment | 8M | 9.49B | (553M) | 592M | (1.28B) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | (38M) | (121M) | (639.67M) |
| Dividends Paid | (1.15B) | (2.68B) | (388M) | (570M) | (598.59M) |
| Other Financing Activities | (96M) | 107M | (589M) | (1.44B) | (39.12M) |
| Financing Cash Flow | (1.24B) | 6.91B | (1.57B) | (1.54B) | (2.55B) |
| Effect of Forex Changes | (5M) | 15M | (15M) | (79M) | 66.6M |
| Net Change in Cash | 82M | 205M | 383M | 1.21B | (769.66M) |
| Free Cash Flow | 1.06B | 1.74B | 1.76B | 2.05B | 1.97B |
Haleon plc
NYSE:HLN
Intrinsic Alpha fair value
Locked
Current Price
$9.08
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.